Overview Powered by AI
Ohara Pharmaceuticals is a leading healthcare-focused venture capital firm in Africa, investing primarily in Series B rounds. With a portfolio including Helium Health, they aim to drive the growth of transformative healthcare solutions for the continent. Their unique focus on Series B sets them apart, enabling them to scale promising healthcare startups and bridge the funding gap.
Ohara Pharmaceuticals' Latest news
No highlight available at this time.
| Round | Startup | Location | Date | Amount Raised |
|---|---|---|---|---|
| Series B | Nigeria | Jun 05, 2023 | $ 30,000,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 | |
| Seed | Nigeria | Mar 23, 2021 | $ 125,000 |
Upgrade to StartupList Africa PRO for unlimited access to this list.
lockUnlock Access to Full ListUnlock more Data
Access more Data and functionalities with our PRO plan.